english English    english 中文

Win-Win Fine Chemical Expert WINWIN Chemicals

On November 9th, Hehuang Pharmaceutical announced FRUZAQLA ? Furuintinib has been approved by the FDA for marketing, becoming the first and only highly selective inhibitor for all three types of VEGF receptor kinases approved for the treatment of metastatic colorectal cancer in the United States, regardless of the patient's biomarker status.
Winwin Cheimcal news